Literature DB >> 17707277

Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.

Matthias Söhn1, Markus Alber, Di Yan.   

Abstract

PURPOSE: The variability of dose-volume histogram (DVH) shapes in a patient population can be quantified using principal component analysis (PCA). We applied this to rectal DVHs of prostate cancer patients and investigated the correlation of the PCA parameters with late bleeding. METHODS AND MATERIALS: PCA was applied to the rectal wall DVHs of 262 patients, who had been treated with a four-field box, conformal adaptive radiotherapy technique. The correlated changes in the DVH pattern were revealed as "eigenmodes," which were ordered by their importance to represent data set variability. Each DVH is uniquely characterized by its principal components (PCs). The correlation of the first three PCs and chronic rectal bleeding of Grade 2 or greater was investigated with uni- and multivariate logistic regression analyses.
RESULTS: Rectal wall DVHs in four-field conformal RT can primarily be represented by the first two or three PCs, which describe approximately 94% or 96% of the DVH shape variability, respectively. The first eigenmode models the total irradiated rectal volume; thus, PC1 correlates to the mean dose. Mode 2 describes the interpatient differences of the relative rectal volume in the two- or four-field overlap region. Mode 3 reveals correlations of volumes with intermediate doses ( approximately 40-45 Gy) and volumes with doses >70 Gy; thus, PC3 is associated with the maximal dose. According to univariate logistic regression analysis, only PC2 correlated significantly with toxicity. However, multivariate logistic regression analysis with the first two or three PCs revealed an increased probability of bleeding for DVHs with more than one large PC.
CONCLUSIONS: PCA can reveal the correlation structure of DVHs for a patient population as imposed by the treatment technique and provide information about its relationship to toxicity. It proves useful for augmenting normal tissue complication probability modeling approaches.

Entities:  

Mesh:

Year:  2007        PMID: 17707277     DOI: 10.1016/j.ijrobp.2007.04.066

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data.

Authors:  Yun Liang; Karen Messer; Brent S Rose; John H Lewis; Steve B Jiang; Catheryn M Yashar; Arno J Mundt; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

2.  A study of the fluorescence characteristics of common cariogenic microorganisms.

Authors:  Haihua Zhu; Weiwei Lao; Qingguang Chen; Qixia Zhang; Hui Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.

Authors:  Jun Lian; Lulin Yuan; Yaorong Ge; Bhishamjit S Chera; David P Yoo; Sha Chang; FangFang Yin; Q Jackie Wu
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

4.  Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.

Authors:  Oscar Acosta; Gael Drean; Juan D Ospina; Antoine Simon; Pascal Haigron; Caroline Lafond; Renaud de Crevoisier
Journal:  Phys Med Biol       Date:  2013-03-26       Impact factor: 3.609

5.  A tensor-based population value decomposition to explain rectal toxicity after prostate cancer radiotherapy.

Authors:  Juan David Ospina; Frédéric Commandeur; Richard Ríos; Gaël Dréan; Juan Carlos Correa; Antoine Simon; Pascal Haigron; Renaud de Crevoisier; Oscar Acosta
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

6.  A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Authors:  Johanne Hermesse; Sylvie Biver; Nicolas Jansen; Eric Lenaerts; Nathalie De Patoul; Stefaan Vynckier; Philippe Coucke; Pierre Scalliet; Philippe Nickers
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

7.  Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Authors:  Lynsey J Hamlett; Andrew J McPartlin; Edward J Maile; Gareth Webster; Ric Swindell; Carl G Rowbottom; Ananya Choudhury; Adam H Aitkenhead
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

8.  Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).

Authors:  Franz Zehentmayr; Matthias Söhn; Ann-Katrin Exeli; Karl Wurstbauer; Almut Tröller; Heinz Deutschmann; Gerd Fastner; Christoph Fussl; Philipp Steininger; Manfred Kranzinger; Claus Belka; Michael Studnicka; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2015-05-28       Impact factor: 3.481

9.  Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer.

Authors:  Antonella Fogliata; Po-Ming Wang; Francesca Belosi; Alessandro Clivio; Giorgia Nicolini; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2014-10-28       Impact factor: 3.481

10.  The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.

Authors:  S Vivekanandan; D B Landau; N Counsell; D R Warren; A Khwanda; S D Rosen; E Parsons; Y Ngai; L Farrelly; L Hughes; M A Hawkins; J D Fenwick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-27       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.